Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C2 | P08235 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | CRHBP | P24387 | 1/20 | 0.46 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.41 |
| ▸ | APAF1 | O14727 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | CASP6 | P55212 | 1/20 | 0.41 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.41 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.41 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18377018 | 0.98 | NR3C2 (0.53) | NR3C2MAPTCRHBPCRHR2NPSR1 | |
| SCHEMBL20160922 | 0.98 | NR3C2 (0.53) | NR3C2MAPTCRHBPCRHR2NPSR1 | |
| SCHEMBL6932587 | 0.98 | NR3C2 (0.52) | NR3C2MAPTCRHBPCRHR2NPSR1 | |
| SCHEMBL20681739 | 0.96 | NR3C2 (0.51) | NR3C2MAPTCRHBPCRHR2NPSR1 | |
| SCHEMBL9565100 | 0.95 | NR3C2 (0.50) | NR3C2MAPTCRHBPCRHR2NPSR1 | |
| SCHEMBL7149333 | 0.93 | NR3C2 (0.60) | NR3C2MAPTCRHBPCRHR2NPSR1 | |
| SCHEMBL409370 | 0.90 | NR3C2 (0.57) | NR3C2MAPTCRHBPCRHR2NPSR1 | |
| SCHEMBL6567347 | 0.90 | NR3C2 (0.57) | NR3C2MAPTCRHBPCRHR2NPSR1 | |
| SCHEMBL12763736 | 0.90 | NR3C2 (0.47) | NR3C2MAPTCRHBPCRHR2NPSR1 | |
| SCHEMBL21390743 | 0.90 | NR3C2 (0.47) | NR3C2MAPTCRHBPCRHR2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6532098-B1 | Sandwiched between two electrically conductive substrates at least one of which is transparent; benzidine or phenylenediamine compounds, acryloyl-modified polyalkylene oxide; viologen compound | NIPPON MITSUBISHI OIL CORPORATION (JP) | 2003-03-11 | — | — | US | claimed |
| EP-1496044-B1 | NOVEL 1,3,5-TRIS(ARYLAMINO)BENZENE | BANDO CHEMICAL IND (JP) | 2010-11-03 | — | — | EP | disclosed |
| US-7271291-B2 | 1,3,5-tris (arylamino) benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2007-09-18 | — | — | US | disclosed |
| US-7196224-B2 | 1,3,5-tris(arylamino)benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2007-03-27 | — | — | US | disclosed |
| US-20060173216-A1 | Novel 1, 3, 5 tris (arylamino) benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2006-08-03 | — | — | US | disclosed |
| US-20050090692-A1 | Novel 1,3,5-tris(arylamino)benzene | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2005-04-28 | — | — | US | disclosed |
| EP-1496044-A1 | NOVEL 1,3,5-TRIS(ARYLAMINO)BENZENE | Bando Chemical Industries, Ltd. (JP) | 2005-01-12 | — | — | EP | disclosed |
| US-6532098-B1 | Sandwiched between two electrically conductive substrates at least one of which is transparent; benzidine or phenylenediamine compounds, acryloyl-modified polyalkylene oxide; viologen compound | NIPPON MITSUBISHI OIL CORPORATION (JP) | 2003-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060173216-A1 | Novel 1, 3, 5 tris (arylamino) benzenes | HSPA4L, HSPA1A, GAPVD1 | NR3C2 4066/4885MAPT 1954/4885CRHBP 4801/4885 |
| US-20050090692-A1 | Novel 1,3,5-tris(arylamino)benzene | AHR, MYB, NAP1L4 | NR3C2 3801/4885MAPT 2513/4885CRHBP 4807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.